Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
Public ClinicalTrials.gov record NCT00336544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blinded, Randomized, Parallel Group, Multi-Center, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300 mg QD to Clarithromycin 250 mg BID for the Treatment of Community-Acquired Pneumonia in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the efficacy and safety of cethromycin to clarithromycin for the treatment of mild to moderate community-acquired pneumonia (CAP).
Study identification
- NCT ID
- NCT00336544
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 522 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Apr 30, 2007
- Completion
- Apr 30, 2007
- Last update posted
- Feb 25, 2010
2006 – 2007
United States locations
- U.S. sites
- 13
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ARGENTINA - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| BULGARIA - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| CHILE - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| CROATIA - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| ESTONIA - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| GERMANY - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| HUNGARY - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| ISRAEL - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| PERU - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| POLAND - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| ROMANIA - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| THE NETHERLANDS - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
| UKRAINE - Advanced Life Sciences | Woodridge | Illinois | 60517 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00336544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 25, 2010 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00336544 live on ClinicalTrials.gov.